Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (301-310 of 441) with videos related to

Pageof 45
Sort By:
NPJ Breast Cancer|January 19, 2022
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBCCharlotte Rypens, François Bertucci, Pascal Finetti, et al.
British Journal of Cancer|June 29, 2016
Prospective changes in global DNA methylation and cancer incidence and mortalityBrian T Joyce, Tao Gao, Yinan Zheng, et al.
Science Advances|January 6, 2023
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicityZiyi Fu, Siqi Chen, Yueming Zhu, et al.
Breast Cancer Research and Treatment|October 25, 2016
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancerChun Wang, Zhaomei Mu, Inna Chervoneva, et al.
The Breast Journal|January 28, 2015
Relationship between circulating tumor cells, blood coagulation, and urokinase-plasminogen-activator system in early breast cancer patientsMichal Mego, Marian Karaba, Gabriel Minarik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2019
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast CancerNicholas C Turner, Yuan Liu, Zhou Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast CancerSaya Jacob, Andrew A Davis, Lorenzo Gerratana, et al.
Future Oncology (London, England)|April 18, 2023
Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i>-mutant breast cancer during first-line treatmentNicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, et al.
Breast Cancer Research and Treatment|August 13, 2020
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trialsRichard S Finn, Massimo Cristofanilli, Johannes Ettl, et al.
Clinical Breast Cancer|March 28, 2007
Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burdenMassimo Cristofanilli, Kristine R Broglio, Valentina Guarneri, et al.
Pageof 45

Showing results (301-310 of 441) with videos related to

Sort By:
Pageof 45
NPJ Breast Cancer|January 19, 2022
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBCCharlotte Rypens, François Bertucci, Pascal Finetti, et al.
British Journal of Cancer|June 29, 2016
Prospective changes in global DNA methylation and cancer incidence and mortalityBrian T Joyce, Tao Gao, Yinan Zheng, et al.
Science Advances|January 6, 2023
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicityZiyi Fu, Siqi Chen, Yueming Zhu, et al.
Breast Cancer Research and Treatment|October 25, 2016
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancerChun Wang, Zhaomei Mu, Inna Chervoneva, et al.
The Breast Journal|January 28, 2015
Relationship between circulating tumor cells, blood coagulation, and urokinase-plasminogen-activator system in early breast cancer patientsMichal Mego, Marian Karaba, Gabriel Minarik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2019
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast CancerNicholas C Turner, Yuan Liu, Zhou Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast CancerSaya Jacob, Andrew A Davis, Lorenzo Gerratana, et al.
Future Oncology (London, England)|April 18, 2023
Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i>-mutant breast cancer during first-line treatmentNicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, et al.
Breast Cancer Research and Treatment|August 13, 2020
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trialsRichard S Finn, Massimo Cristofanilli, Johannes Ettl, et al.
Clinical Breast Cancer|March 28, 2007
Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burdenMassimo Cristofanilli, Kristine R Broglio, Valentina Guarneri, et al.
Pageof 45